G. Chen

1.1k total citations
54 papers, 403 citations indexed

About

G. Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, G. Chen has authored 54 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 13 papers in Surgery. Recurrent topics in G. Chen's work include Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). G. Chen is often cited by papers focused on Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). G. Chen collaborates with scholars based in China, United States and Hong Kong. G. Chen's co-authors include Lin Wu, Ying Cheng, Q. Wang, Jianxing He, K. Li, Haifeng Qin, Jingyun Shi, Chunyan Zhu, Yi‐Long Wu and Fuqing Lin and has published in prestigious journals such as Journal of Colloid and Interface Science, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

G. Chen

49 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Chen China 11 224 165 102 85 76 54 403
Nan Hu China 12 193 0.9× 297 1.8× 83 0.8× 32 0.4× 76 1.0× 45 584
Yasuyuki Miyauchi Japan 12 193 0.9× 113 0.7× 186 1.8× 63 0.7× 59 0.8× 42 471
Alistair Cook Australia 13 310 1.4× 254 1.5× 36 0.4× 20 0.2× 110 1.4× 30 691
Xin Fan China 10 120 0.5× 85 0.5× 33 0.3× 20 0.2× 134 1.8× 28 463
P.L. Jager Netherlands 15 135 0.6× 153 0.9× 195 1.9× 65 0.8× 57 0.8× 30 792
Dan Yaniv Israel 11 73 0.3× 60 0.4× 120 1.2× 37 0.4× 26 0.3× 39 324
Zairong Gao China 13 67 0.3× 100 0.6× 72 0.7× 62 0.7× 122 1.6× 32 429
Patrik Palacka Slovakia 12 119 0.5× 135 0.8× 221 2.2× 25 0.3× 143 1.9× 72 450
W. T. Knoefel Germany 11 204 0.9× 115 0.7× 194 1.9× 96 1.1× 58 0.8× 30 419
Yugo Kanai Japan 12 125 0.6× 60 0.4× 46 0.5× 78 0.9× 138 1.8× 21 444

Countries citing papers authored by G. Chen

Since Specialization
Citations

This map shows the geographic impact of G. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Chen more than expected).

Fields of papers citing papers by G. Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Chen. The network helps show where G. Chen may publish in the future.

Co-authorship network of co-authors of G. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of G. Chen. A scholar is included among the top collaborators of G. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Chen. G. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Tingting, G. Chen, Jun Yao, et al.. (2025). Muscle strength trajectories and outcomes in critically ill patients: A prospective multicentre cohort study. Intensive and Critical Care Nursing. 88. 103934–103934. 1 indexed citations
2.
Cheng, Shaoyin, et al.. (2025). An empirical study on the effectiveness of large language models for binary code understanding. Empirical Software Engineering. 31(1).
3.
4.
Chen, G., Hao Sun, Yunxia Chen, et al.. (2024). Perineural Invasion in Cervical Cancer: A Hidden Trail for Metastasis. Diagnostics. 14(14). 1517–1517. 2 indexed citations
5.
Zheng, Zhen, Li Xiao, G. Chen, et al.. (2023). Transcriptome analyses reveal new insights on key determinants of perineural invasion in high-grade serous ovarian cancer. Frontiers in Cell and Developmental Biology. 11. 1109710–1109710. 3 indexed citations
6.
7.
Shi, Yuankai, et al.. (2022). 31P Efficacy and safety of utidelone in treatment-refractory advanced non-small cell lung cancer. Annals of Oncology. 33. S45–S46. 1 indexed citations
8.
Chen, G., et al.. (2021). Stress Hormones: Emerging Targets in Gynecological Cancers. Frontiers in Cell and Developmental Biology. 9. 699487–699487. 9 indexed citations
9.
Wang, Zhenwei, Di Ai, Teng Zhang, et al.. (2020). Multidisciplinary team for treatment of hip fracture in the elderly. Zhonghua chuangshang guke zazhi. 22(3). 200–205. 1 indexed citations
10.
11.
12.
13.
Ren, Shengxiang, Jun Zhao, G. Chen, et al.. (2020). 1267P Efficacy of camrelizumab (SHR-1210) plus apatinib as second-line treatment for advanced squamous NSCLC. Annals of Oncology. 31. S819–S819. 2 indexed citations
14.
15.
Fang, Jian, Yongqian Shu, Dan Wang, et al.. (2019). OA01.08 A Phase I Study to Evaluate Safety and Antitumor Activity of BPI-7711 in EGFRM+/T790M+ Advanced or Recurrent NSCLC Patients. Journal of Thoracic Oncology. 14(11). S1126–S1127. 2 indexed citations
16.
Cheng, Ying, Q. Wang, K. Li, et al.. (2019). P2.12-26 The Impact of Anlotinib for Relapsed SCLC Patients with Brain Metastases: A Subgroup Analysis of ALTER 1202. Journal of Thoracic Oncology. 14(10). S823–S824. 7 indexed citations
17.
Wang, Q., Ying Cheng, K. Li, et al.. (2019). OA03.02 Effect of Anlotinib in Advanced Small Cell Lung Cancer Patients Previously Received Chemoradiotherapy: A Subgroup Analysis in ALTER 1202 Trial. Journal of Thoracic Oncology. 14(10). S211–S211. 3 indexed citations
18.
Li, K., Ying Cheng, Q. Wang, et al.. (2019). P2.12-11 Quality of Life in ALTER1202 Trial of Anlotinib as Third-or Further Line Therapy for Advanced Small Cell Lung Cancer (SCLC): A Post-Hoc Analysis. Journal of Thoracic Oncology. 14(10). S816–S816. 3 indexed citations
19.
Cheng, Ying, Q. Wang, K. Li, et al.. (2018). OA13.03 Anlotinib as Third-Line or Further-Line Treatment in Relapsed SCLC: A Multicentre, Randomized, Double-Blind Phase 2 Trial. Journal of Thoracic Oncology. 13(10). S351–S352. 47 indexed citations
20.
Zhu, Haitao, Wenjing Li, Zhongwei Liu, et al.. (2017). Selection of Implantation Sites for Transplantation of Encapsulated Pancreatic Islets. Tissue Engineering Part B Reviews. 24(3). 191–214. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nan Hu Breakdown of academic impact, for papers by Yasuyuki Miyauchi Breakdown of academic impact, for papers by Alistair Cook Breakdown of academic impact, for papers by Xin Fan Breakdown of academic impact, for papers by P.L. Jager Breakdown of academic impact, for papers by Dan Yaniv Breakdown of academic impact, for papers by Zairong Gao Breakdown of academic impact, for papers by Patrik Palacka Breakdown of academic impact, for papers by W. T. Knoefel Breakdown of academic impact, for papers by Yugo Kanai
Rankless by CCL
2026